triazoles has been researched along with Community Acquired Infection in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 16 (88.89) | 24.3611 |
2020's | 2 (11.11) | 2.80 |
Authors | Studies |
---|---|
Andrade, RB; Barnett, PR; Daher, SS; Freundlich, JS; Jin, X; Lee, M; Teijaro, CN | 1 |
Al-Uzri, A; Benjamin, DK; Borja-Tabora, CFC; Bosheva, M; Bradley, JS; Cohen-Wolkowiez, M; Di John, D; Elliott, C; Ericson, JE; Friedel, D; Gonczi, F; Hornik, C; Hornik, CP; Isidro, MGD; James, LP; Kalocsai, K; Koutroulis, I; Laki, I; Lang, JE; Mendez Echevarria, A; Nad, M; Ong-Lim, ALT; Silverstein, A; Simon, G; Syed, S; Szabo, E | 1 |
Aitken, SL; Brown, JE; Buege, MJ | 1 |
Cohen-Wolkowiez, M; Edginton, A; Gonzalez, D; Hornik, CP; Jamieson, BD; Salerno, SN; Watt, KM | 1 |
Evans, D; Fernandes, P; Pereira, D; Wu, S; Yalkowsky, S | 1 |
Deol, HS; Donald, BJ; Mbadugha, UJ; Surani, S; Udeani, G | 1 |
Fernandes, P; Jamieson, BD; Keedy, K; MacLauchlin, C; Schneider, SE | 1 |
Chen, F; Wang, X; Wen, J; Zhao, M | 1 |
Clark, K; Craft, JC; Das, A; Fernandes, P; Jamieson, BD; Oldach, D; Schranz, J; Scott, D | 1 |
Farrell, DJ; Jones, RN; Mendes, RE | 1 |
Mushtaq, A | 1 |
Tulkens, PM; Van Bambeke, F | 1 |
Antonovsky, Y; Barrera, CM; Clark, K; Das, AF; Doreski, PA; Fernandes, P; Flores-Figueroa, J; Horwith, G; Jamieson, B; Karimjee, N; Keedy, K; Metev, H; Mitha, I; Molina, JM; Mykietiuk, A; Nitu, MF; Oldach, D; Rewerska, B; Rowe, BH; Scott, D; Sheets, A; Tanaseanu, CM; Van Rensburg, DJ | 1 |
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
Das, AF; Fernandes, P; File, TM; Gonong, JRV; Jamieson, BD; Keedy, K; Oldach, D; Rewerska, B; Sheets, A; Taylor, D; Vucinic-Mihailovic, V | 1 |
CarratalĂ , J; Ramos, L; Ramos, O; Simonetti, AF; Viasus, D | 1 |
Adam, H; Gin, AS; Golden, A; Gorityala, B; Hartel, E; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Lynch, JP; Schweizer, F; Walkty, AJ; Zelenitsky, S; Zhanel, GG; Zhanel, MA | 1 |
Biedenbach, DJ; Castanheira, M; Farrell, DJ; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
5 review(s) available for triazoles and Community Acquired Infection
Article | Year |
---|---|
Solithromycin: A novel ketolide antibiotic.
Topics: Animals; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Community-Acquired Infections; Drug Approval; Drug Resistance, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Triazoles; United States; United States Food and Drug Administration | 2017 |
Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Molecular Conformation; Pneumonia, Bacterial; Streptococcus pneumoniae; Triazoles | 2017 |
Solithromycin monotherapy for treatment of community-acquired bacterial pneumonia: A meta-analysis of randomised controlled trials.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Macrolides; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Triazoles | 2019 |
The role of solithromycin in the management of bacterial community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Community-Acquired Infections; Humans; Macrolides; Triazoles | 2016 |
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
Topics: Animals; Anti-Bacterial Agents; Community-Acquired Infections; Humans; Macrolides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Streptococcus pneumoniae; Triazoles | 2016 |
4 trial(s) available for triazoles and Community Acquired Infection
Article | Year |
---|---|
Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Community-Acquired Infections; Humans; Macrolides; Pneumonia, Bacterial; Triazoles | 2022 |
Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Community-Acquired Infections; Double-Blind Method; Female; Humans; Levofloxacin; Macrolides; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome; Triazoles; Young Adult | 2013 |
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Europe; Female; Fluoroquinolones; Humans; Latin America; Macrolides; Male; Middle Aged; Moxifloxacin; North America; Pneumonia, Bacterial; South Africa; Triazoles; Young Adult | 2016 |
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Treatment Outcome; Triazoles | 2016 |
9 other study(ies) available for triazoles and Community Acquired Infection
Article | Year |
---|---|
Alternative approaches utilizing click chemistry to develop next-generation analogs of solithromycin.
Topics: Anti-Bacterial Agents; Click Chemistry; Community-Acquired Infections; Humans; Macrolides; Microbial Sensitivity Tests; Triazoles | 2022 |
Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Community-Acquired Infections; Computer Simulation; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Intravenous; Macrolides; Models, Biological; Pneumonia, Bacterial; Predictive Value of Tests; Triazoles | 2017 |
Overcoming the Challenges of Low Drug Solubility in the Intravenous Formulation of Solithromycin.
Topics: Administration, Intravenous; Amino Acids; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Community-Acquired Infections; Drug-Related Side Effects and Adverse Reactions; Humans; Macrolides; Solubility; Tartrates; Triazoles | 2018 |
Metabolism, Excretion, and Mass Balance of Solithromycin in Humans.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Cytochrome P-450 CYP3A; Humans; Macrolides; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Triazoles; Young Adult | 2018 |
Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Protein Tyrosine Phosphatases; Streptococcus pneumoniae; Triazoles; United States | 2015 |
Solithromycin to treat community-acquired pneumonia?
Topics: Aged; Community-Acquired Infections; Humans; Macrolides; Pneumonia; Triazoles | 2015 |
Results from the Solithromycin International Surveillance Program (2014).
Topics: Anti-Bacterial Agents; Asia; Azithromycin; Bacterial Infections; Community-Acquired Infections; Epidemiological Monitoring; Europe; Haemophilus influenzae; Humans; International Cooperation; Ketolides; Latin America; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Triazoles; United States | 2016 |
Solithromycin for the treatment of community-acquired bacterial pneumonia.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Humans; Macrolides; Pneumonia, Bacterial; Streptococcus pneumoniae; Triazoles | 2017 |
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Triazoles | 2010 |